A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis
Clinical trial NCT05437419 · COMPLETED
Trial details
- NCT number
- NCT05437419
- Sponsor
- Teijin America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2023-07-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.